CNPAX
Price
$73.30
Change
+$0.37 (+0.51%)
Updated
Dec 3 closing price
Net Assets
162.64B
PRJQX
Price
$49.96
Change
+$0.20 (+0.40%)
Updated
Dec 3 closing price
Net Assets
6B
Interact to see
Advertisement

CNPAX vs PRJQX

Header iconCNPAX vs PRJQX Comparison
Open Charts CNPAX vs PRJQXBanner chart's image
American Funds New Perspective 529A
Price$73.30
Change+$0.37 (+0.51%)
VolumeN/A
Net Assets162.64B
PGIM Jennison Global Opportunities R6
Price$49.96
Change+$0.20 (+0.40%)
VolumeN/A
Net Assets6B
CNPAX vs PRJQX Comparison Chart in %
View a ticker or compare two or three
VS
CNPAX vs. PRJQX commentary
Dec 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNPAX is a Buy and PRJQX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CNPAX has more cash in the bank: 163B vs. PRJQX (6B). CNPAX pays higher dividends than PRJQX: CNPAX (0.46) vs PRJQX (0.00). CNPAX was incepted earlier than PRJQX: CNPAX (24 years) vs PRJQX (11 years). PRJQX (0.82) is less costly to investors than CNPAX (0.77). PRJQX is a more actively managed with annual turnover of: 66.00 vs. CNPAX (24.00). PRJQX has a lower initial minimum investment than CNPAX: PRJQX (0) vs CNPAX (250). CNPAX annual gain was more profitable for investors over the last year : 11.91 vs. PRJQX (-0.75). CNPAX return over 5 years is better than : 25.34 vs. PRJQX (10.19).
CNPAXPRJQXCNPAX / PRJQX
Total Expense Ratio0.770.8294%
Annual Report Gross Expense Ratio0.770.8294%
Fund Existence24 years11 years-
Gain YTD20.1058.350241%
Front Load4%N/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets163B6B2,717%
Annual Yield % from dividends0.460.00-
Returns for 1 year11.91-0.75-1,578%
Returns for 3 years46.1065.3271%
Returns for 5 years25.3410.19249%
Returns for 10 years101.99210.8948%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CTNM11.120.63
+6.01%
Contineum Therapeutics
LOB33.281.11
+3.45%
Live Oak Bancshares
ALSN90.521.20
+1.34%
Allison Transmission Holdings
ATMVU7.75N/A
N/A
AlphaVest Acquisition Corp
CTSO0.73-0.04
-4.67%
Cytosorbents Corp